Moonlake Immunotherapeutics · NASDAQ:MLTX

Reich Kristian sold 52,448 Moonlake Immunotherapeutics shares (Form 4)

Traded Jul 21 to Jul 22, 2026 · Filed Jul 23, 2026

From Jul 21 to Jul 22, 2026, Reich Kristian (Chief Scientific Officer) sold 52,448 Moonlake Immunotherapeutics shares at an average US$20.02 for US$1.05M under a trading plan, leaving 2,712,298 shares. Filed Jul 23, 2026 (Form 4).

Sold
52,448 shares
Price
US$20.02 average (US$20.00 to US$20.02)
Value
US$1.05M
Holding after
2,712,298 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 21, 2026Class A ordinary shares, par value $0.0001 per shareSale50,000US$20.022,714,746Indirect
Jul 22, 2026Class A ordinary shares, par value $0.0001 per shareSale2,448US$20.002,712,298Indirect

Source

View original at SEC

Related